ECSP088907A - VACCINE AGAINST RICKETTSIA SIMILAR ORGANISMS - Google Patents

VACCINE AGAINST RICKETTSIA SIMILAR ORGANISMS

Info

Publication number
ECSP088907A
ECSP088907A EC2008008907A ECSP088907A ECSP088907A EC SP088907 A ECSP088907 A EC SP088907A EC 2008008907 A EC2008008907 A EC 2008008907A EC SP088907 A ECSP088907 A EC SP088907A EC SP088907 A ECSP088907 A EC SP088907A
Authority
EC
Ecuador
Prior art keywords
vaccine against
similar organisms
rickettsia
against rickettsia
similar
Prior art date
Application number
EC2008008907A
Other languages
Spanish (es)
Inventor
Luc Grisez
Chow Yong Ng
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of ECSP088907A publication Critical patent/ECSP088907A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere al uso de bacterias del género Estreptococo para la fabricación de una vacuna para combatir la infección provocada por el organismo similar a Rickettsia.The present invention relates to the use of bacteria of the genus Streptococcus for the manufacture of a vaccine to combat infection caused by the organism similar to Rickettsia.

EC2008008907A 2006-05-30 2008-11-21 VACCINE AGAINST RICKETTSIA SIMILAR ORGANISMS ECSP088907A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80966006P 2006-05-30 2006-05-30
EP06114710 2006-05-30

Publications (1)

Publication Number Publication Date
ECSP088907A true ECSP088907A (en) 2008-12-30

Family

ID=38432974

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2008008907A ECSP088907A (en) 2006-05-30 2008-11-21 VACCINE AGAINST RICKETTSIA SIMILAR ORGANISMS

Country Status (4)

Country Link
CR (1) CR10457A (en)
EC (1) ECSP088907A (en)
MX (1) MX2008015164A (en)
WO (1) WO2007138036A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200936759A (en) * 2007-12-21 2009-09-01 Intervet Int Bv Fish vaccine
TWI551295B (en) 2008-04-18 2016-10-01 英特威特國際股份有限公司 Prevention of vaccines for Lawsonia intracellularis
TWI449533B (en) 2008-04-18 2014-08-21 Intervet Int Bv Vaccine for protection against lawsonia intracellularis, mycoplasma hyopneumoniae and porcine circo virus
WO2011048041A1 (en) * 2009-10-19 2011-04-28 Intervet International B.V. Streptococcal combi-vaccine
KR101976764B1 (en) * 2017-12-19 2019-05-09 제주대학교 산학협력단 Tenacibaculum maritimum virulence attenuation technique and live attenuated vaccine for preventing fish Tenacibaculosis disease
KR101992455B1 (en) * 2018-09-11 2019-06-24 제주대학교 산학협력단 Tenacibaculum maritimum virulence attenuation technique and live attenuated vaccine for preventing fish Tenacibaculosis disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6379677B1 (en) * 2000-02-25 2002-04-30 The United States Of America As Represented By The Secretary Of The Department Of Agriculture Streptococcus iniae vaccine

Also Published As

Publication number Publication date
WO2007138036A1 (en) 2007-12-06
MX2008015164A (en) 2008-12-12
CR10457A (en) 2009-02-26

Similar Documents

Publication Publication Date Title
ES2523968T3 (en) Antibacterial combination therapy for the treatment of infections by Gram-positive bacteria
CY1121175T1 (en) SUPPRESSION OF BIO-MEMBRANE ORGANISMS
CO6751260A2 (en) OMV-based vaccines against burkholderia infections
CL2011000939A1 (en) Compounds derived from cephalosporins substituted by a catechol group, with antimicrobial activity against gram-negative bacteria that produce beta-lactamase; pharmaceutical composition that includes them; use in the treatment of infectious diseases.
GT200900230A (en) 4-ARIL-1,4-DIHIDRO-1,6-NAFTIRIDINAMIDES REPLACED AND USE
CA2798214C (en) Vaccine against beta-herpesvirus infection and use thereof
DOP2012000299A (en) 5-FLUORO-1H-REPLACED PIRAZOLOPIRIDINES AND ITS USE
CL2012002902A1 (en) Specific bacteriophage strains against bacteria belonging to the genus vibrio for the prophylaxis and therapy of vibrio anguillarum; and antibacterial composition comprising said strains.
BR112013011263A2 (en) "nematicidal composition, and method for controlling nematodes"
CU20110083A7 (en) FUSIONED SPIROCYCLIC HETEROAROMATIC COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS
DOP2009000287A (en) OXAZOLIDINONES REPLACED AND ITS USE
MX353908B (en) USE OF HYDROGEN PEROXIDE PRODUCTION BACTERIA FOR WHITENING TEETH.
UA107204C2 (en) ANTI-FUNCTIONAL COMPOSITION CONTAINING THE PYTHIUM OLIGANDRUM Fungal Organism
UY31437A1 (en) MYCOPLASMA BOVIS VACCINE AND SAME USE METHODS
CL2016001524A1 (en) Antibacterial derivatives of 1h-indazole and 1h-indole.
CL2009000990A1 (en) Use of epothilone d for the treatment of diseases associated with tau, such as Alzheimer's disease, Parkinson's, among others.
MX2017009094A (en) DERIVED FROM POLYMIXINE AND USES OF THE SAME.
CL2011001284A1 (en) Procedure for the production of vaccines against bacterial pathogens that produce an ab toxin; vaccine comprising clostridium toxoid a and / or b; use of said vaccine against infections of pathogens that produce toxins ab.
UY31133A1 (en) "SUBSTITUTED OXAZOLIDINONES AND ITS USE"
BR112022005345A2 (en) IMMUNOGENIC COMPOSITIONS
BR112012024999A2 (en) combination and use
BR112012021383A2 (en) infection treatment or prevention
ECSP099066A (en) ESTREPTOCOCICA COMBINED VACCINE
AR053775A1 (en) NONADEPSIPEPTIDES ACILATED II
WO2011029536A3 (en) Use of cyclic keto-enols for combating plant pathogenic bacteria